Skip to main content

Find Clinical Trials

Home
Conditions
Skin Diseases, Metabolic

Clinical trial condition

Skin Diseases, Metabolic

Explore clinical trials studying Skin Diseases, Metabolic. Study availability and eligibility vary by location and protocol.

136 public trials 14 recruiting studies

Refine in advanced search Browse all conditions

Skin Diseases, Metabolic trial results

Completed

A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients

NCT00005106

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +18 more
Locations: Univ of Alabama at Birmingham Birmingham, Alabama, United States

Arizona Clinical Research Ctr Inc Tucson, Arizona, United States

Longbeach Memorial Med Ctr Longbeach, California, United States

Good Samaritan Hosp Los Angeles, California, United States

View all 39 locations

View Trial Details

Completed

Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy

NCT00004329

Conditions: Disease Attributes, Endocrine System Diseases, Lipid Metabolism Disorders, +9 more
Locations: University of Texas Medical Branch Galveston, Texas, United States

View Trial Details

Completed

A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients

NCT00005764

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +18 more
Locations: THE Clinic Los Angeles, California, United States

Tower Infectious Disease Med Ctr Los Angeles, California, United States

St Lukes Medical Group San Diego, California, United States

UCSD Treatment Ctr San Diego, California, United States

View all 31 locations

View Trial Details

Active, Not Recruiting

Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy

NCT02262806

Conditions: Diabetes, Diabetes Mellitus, Dyslipidemias, +12 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy

NCT02262832

Conditions: Diabetes, Diabetes Mellitus, Dyslipidemias, +12 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)

NCT06548100

Conditions: Body Weight, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diabetes Mellitus, +28 more
Locations: National Institutes of Health Bethesda, Maryland, United States

University of Michigan Ann Arbor, Michigan, United States

View Trial Details